• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在亚太地区根除间日疟:亚太疟疾消除网络间日疟工作组

Targeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working Group.

出版信息

Malar J. 2015 Dec 1;14:484. doi: 10.1186/s12936-015-0958-y.

DOI:10.1186/s12936-015-0958-y
PMID:26627892
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4667409/
Abstract

The Asia Pacific Malaria Elimination Network (APMEN) is a collaboration of 18 country partners committed to eliminating malaria from within their borders. Over the past 5 years, APMEN has helped to build the knowledge, tools and in-country technical expertise required to attain this goal. At its inaugural meeting in Brisbane in 2009, Plasmodium vivax infections were identified across the region as a common threat to this ambitious programme; the APMEN Vivax Working Group was established to tackle specifically this issue. The Working Group developed a four-stage strategy to identify knowledge gaps, build regional consensus on shared priorities, generate evidence and change practice to optimize malaria elimination activities. This case study describes the issues faced and the solutions found in developing this robust strategic partnership between national programmes and research partners within the Working Group. The success of the approach adopted by the group may facilitate similar applications in other regions seeking to deploy evidence-based policy and practice.

摘要

亚太疟疾消除网络(APMEN)是由18个国家伙伴组成的合作组织,致力于在其境内消除疟疾。在过去5年里,APMEN帮助积累了实现这一目标所需的知识、工具和国内技术专长。在2009年于布里斯班举行的首届会议上,间日疟原虫感染被确定为该雄心勃勃计划在整个区域面临的一个共同威胁;为此成立了APMEN间日疟工作组来专门应对这一问题。该工作组制定了一个四阶段战略,以找出知识差距、就共同优先事项形成区域共识、提供证据并改变做法,从而优化疟疾消除活动。本案例研究描述了在工作组内国家项目与研究伙伴之间建立这种强有力的战略伙伴关系过程中所面临的问题及找到的解决办法。该小组所采用方法的成功可能会促进其他寻求采用循证政策和做法的区域进行类似应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29c/4667409/026d9415ce31/12936_2015_958_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29c/4667409/026d9415ce31/12936_2015_958_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a29c/4667409/026d9415ce31/12936_2015_958_Fig1_HTML.jpg

相似文献

1
Targeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working Group.在亚太地区根除间日疟:亚太疟疾消除网络间日疟工作组
Malar J. 2015 Dec 1;14:484. doi: 10.1186/s12936-015-0958-y.
2
Malaria elimination gaining ground in the Asia Pacific.在亚太地区,疟疾消除工作取得进展。
Malar J. 2012 Oct 18;11:346. doi: 10.1186/1475-2875-11-346.
3
Gaps in research and capacity development for malaria surveillance and response in the Asia-Pacific: meeting report.亚太地区疟疾监测和应对方面的研究和能力建设差距:会议报告。
Malar J. 2023 Mar 10;22(1):91. doi: 10.1186/s12936-023-04459-9.
4
Further evidence needed to change policy for the safe and effective radical cure of vivax malaria: Insights from the 2019 annual APMEN Vivax Working Group meeting.改变间日疟安全有效根治政策所需的进一步证据:来自2019年APMEN间日疟工作组年度会议的见解
Asia Pac Policy Stud. 2021 May;8(2):208-242. doi: 10.1002/app5.314. Epub 2021 Jan 12.
5
Targeting populations at higher risk for malaria: a survey of national malaria elimination programmes in the Asia Pacific.针对疟疾高风险人群:亚太地区国家疟疾消除计划调查
Malar J. 2016 May 10;15(1):271. doi: 10.1186/s12936-016-1319-1.
6
Dynamics of Plasmodium vivax populations in border areas of the Greater Mekong sub-region during malaria elimination.消除疟疾期间大湄公河次区域边境地区间日疟原虫种群动态。
Malar J. 2020 Apr 8;19(1):145. doi: 10.1186/s12936-020-03221-9.
7
Implementing parasite genotyping into national surveillance frameworks: feedback from control programmes and researchers in the Asia-Pacific region.将寄生虫基因分型纳入国家监测框架:来自亚太地区控制项目和研究人员的反馈。
Malar J. 2020 Jul 27;19(1):271. doi: 10.1186/s12936-020-03330-5.
8
Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group.定量评估伯氨喹疗效和提高患者服药依从性:APMEN 卵形疟工作组圆桌讨论。
Malar J. 2018 Jun 20;17(1):241. doi: 10.1186/s12936-018-2380-8.
9
Plasmodium vivax: a roadblock on the quest to eliminate malaria.间日疟原虫:消除疟疾征程上的一个障碍。
Lancet Infect Dis. 2015 Oct;15(10):1127-1128. doi: 10.1016/S1473-3099(15)00237-6. Epub 2015 Jul 25.
10
Asymptomatic Plasmodium vivax parasitaemia in the low-transmission setting: the role for a population-based transmission-blocking vaccine for malaria elimination.低传播地区无症状间日疟原虫血症:用于消除疟疾的基于人群的传播阻断疫苗的作用。
Malar J. 2018 Feb 21;17(1):89. doi: 10.1186/s12936-018-2243-3.

引用本文的文献

1
Piloting the options assessment toolkit with national malaria programme leaders from the Asia-Pacific countries: a meeting report.与亚太国家国家疟疾规划负责人共同试用选项评估工具包:会议报告
Malar J. 2025 Jun 12;24(1):187. doi: 10.1186/s12936-025-05432-4.
2
Lessons for improved COVID-19 surveillance from the scale-up of malaria testing strategies.从疟疾检测策略的扩大推广中吸取改进 COVID-19 监测的经验教训。
Malar J. 2022 Jul 20;21(1):223. doi: 10.1186/s12936-022-04240-4.
3
Identifying forms of interventions towards cross border malaria in the Asia-Pacific region: a scoping review protocol.

本文引用的文献

1
Contrasting Transmission Dynamics of Co-endemic Plasmodium vivax and P. falciparum: Implications for Malaria Control and Elimination.间日疟原虫和恶性疟原虫共同流行的不同传播动态:对疟疾控制和消除的影响
PLoS Negl Trop Dis. 2015 May 7;9(5):e0003739. doi: 10.1371/journal.pntd.0003739. eCollection 2015 May.
2
Plasmodium vivax populations are more genetically diverse and less structured than sympatric Plasmodium falciparum populations.间日疟原虫群体比同域分布的恶性疟原虫群体在基因上更加多样化,且结构更松散。
PLoS Negl Trop Dis. 2015 Apr 15;9(4):e0003634. doi: 10.1371/journal.pntd.0003634. eCollection 2015 Apr.
3
确定亚太地区跨境疟疾干预形式:范围综述方案。
BMJ Open. 2022 Feb 15;12(2):e056265. doi: 10.1136/bmjopen-2021-056265.
4
Further evidence needed to change policy for the safe and effective radical cure of vivax malaria: Insights from the 2019 annual APMEN Vivax Working Group meeting.改变间日疟安全有效根治政策所需的进一步证据:来自2019年APMEN间日疟工作组年度会议的见解
Asia Pac Policy Stud. 2021 May;8(2):208-242. doi: 10.1002/app5.314. Epub 2021 Jan 12.
5
Opening the policy blackbox: unravelling the process for changing national diagnostic and treatment guidelines for vivax malaria in seven countries.打开政策黑箱:揭示七个国家改变间日疟诊断和治疗指南的过程。
Malar J. 2021 Oct 30;20(1):428. doi: 10.1186/s12936-021-03959-w.
6
Implementing parasite genotyping into national surveillance frameworks: feedback from control programmes and researchers in the Asia-Pacific region.将寄生虫基因分型纳入国家监测框架:来自亚太地区控制项目和研究人员的反馈。
Malar J. 2020 Jul 27;19(1):271. doi: 10.1186/s12936-020-03330-5.
7
Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group.定量评估伯氨喹疗效和提高患者服药依从性:APMEN 卵形疟工作组圆桌讨论。
Malar J. 2018 Jun 20;17(1):241. doi: 10.1186/s12936-018-2380-8.
8
Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms.在间日疟原虫抗复发治疗中禁用伯氨喹:G6PD 缺乏症和细胞色素 P-450 2D6 多态性的问题。
Malar J. 2018 Jan 22;17(1):42. doi: 10.1186/s12936-018-2190-z.
9
Regional initiatives for malaria elimination: Building and maintaining partnerships.消除疟疾的区域倡议:建立和维持伙伴关系。
PLoS Med. 2017 Oct 5;14(10):e1002401. doi: 10.1371/journal.pmed.1002401. eCollection 2017 Oct.
10
Barriers to routine G6PD testing prior to treatment with primaquine.在使用伯氨喹啉治疗前进行常规葡萄糖-6-磷酸脱氢酶(G6PD)检测的障碍。
Malar J. 2017 Aug 10;16(1):329. doi: 10.1186/s12936-017-1981-y.
Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests.
用于G6PD活性定量评估的毛细血管血的适用性及G6PD即时检测的性能
Am J Trop Med Hyg. 2015 Apr;92(4):818-824. doi: 10.4269/ajtmh.14-0696. Epub 2015 Feb 2.
4
Systematic review of sub-microscopic P. vivax infections: prevalence and determining factors.间日疟原虫亚显微感染的系统评价:患病率及决定因素
PLoS Negl Trop Dis. 2015 Jan 8;9(1):e3413. doi: 10.1371/journal.pntd.0003413. eCollection 2015 Jan.
5
Rapid diagnostic tests for diagnosing uncomplicated non-falciparum or Plasmodium vivax malaria in endemic countries.用于在疟疾流行国家诊断非复杂性非恶性疟或间日疟的快速诊断检测。
Cochrane Database Syst Rev. 2014 Dec 18;2014(12):CD011431. doi: 10.1002/14651858.CD011431.
6
Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia.间日疟原虫疟疾所致死亡率:来自印度尼西亚巴布亚的临床审计
BMC Med. 2014 Nov 18;12:217. doi: 10.1186/s12916-014-0217-z.
7
Clonal outbreak of Plasmodium falciparum infection in eastern Panama.巴拿马东部恶性疟原虫感染的克隆性暴发。
J Infect Dis. 2015 Apr 1;211(7):1087-96. doi: 10.1093/infdis/jiu575. Epub 2014 Oct 21.
8
Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis.间日疟原虫氯喹耐药的全球范围:一项系统评价和荟萃分析
Lancet Infect Dis. 2014 Oct;14(10):982-91. doi: 10.1016/S1473-3099(14)70855-2. Epub 2014 Sep 8.
9
Tracking malaria parasites in the eradication era.在疟疾根除时代追踪疟原虫
Trends Parasitol. 2014 Oct;30(10):465-6. doi: 10.1016/j.pt.2014.08.003. Epub 2014 Aug 22.
10
Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency.葡萄糖-6-磷酸脱氢酶缺乏症的定量和定性检测比较。
Am J Trop Med Hyg. 2014 Oct;91(4):854-861. doi: 10.4269/ajtmh.14-0194. Epub 2014 Jul 28.